News &amp; Updates

The use of the 2022 ESC/ERC definitions of pulmonary arterial hypertension (PAH) has led to the identification of cirrhosis patients with early-stage portopulmonary hypertension (PoPH), who are at greater risk of death, reports a study.

Early PoPH linked to mortality in patients with cirrhosis

Post-COVID syndrome relief may just be a song away

12 Feb 2026 by

A study conducted in Germany demonstrates the feasibility of singing-based respiratory training (SBRT) among individuals with post-COVID syndrome (PCS) with respiratory disorders.

Post-COVID syndrome relief may just be a song away

HDL-C a potential marker of functional outcome in ischaemic stroke

Elevated concentrations of high-density lipoprotein cholesterol (HDL-C) are associated with favourable functional recovery in patients with ischaemic stroke, as suggested in a recent study.

HDL-C a potential marker of functional outcome in ischaemic stroke

People with evening chronotype may have poorer heart health

Middle aged or older people with an evening chronotype are at increased risk of cardiovascular disease (CVD), owing to their unfavourable cardiovascular health profile, according to a study.

People with evening chronotype may have poorer heart health

Hypertension ups risks of adverse outcomes, fibrosis progression in MASLD

Patients with metabolic dysfunction-associated steatotic liver disease (MASLD), who also happen to have hypertension, are at much greater risk of adverse clinical outcomes and progression of liver stiffness and fibrosis, according to a study.

Hypertension ups risks of adverse outcomes, fibrosis progression in MASLD

Nivolumab-ipilimumab combo plus surgery improves survival in HCC

Patients with potentially resectable hepatocellular carcinoma (HCC) may receive neoadjuvant nivolumab plus ipilimumab therapy, followed by surgery, to improve their survival, suggests a study.

Nivolumab-ipilimumab combo plus surgery improves survival in HCC

11 Feb 2026

UPF consumption higher in rural vs urban areas among US adults

A US study has observed greater consumption of ultraprocessed food (UPF) among adults living in rural areas than those in urban areas, with a few significant differences by urbanization among youth.

UPF consumption higher in rural vs urban areas among US adults

Prophylactic marstacimab fares well in haemophilia A or B without inhibitors

Results of the BASIS trial demonstrate the efficacy and safety of once-weekly SC marstacimab prophylaxis up to 12 months in male adolescents and adults with severe haemophilia A* (HA) or severe-to-moderately-severe haemophilia B** (HB) with no detectable or documented history of inhibitors against factors VIII or IX, and who were receiving on-demand (OD) or routine prophylaxis (RP) prior to enrolment.

Prophylactic marstacimab fares well in haemophilia A or B without inhibitors

Harnessing the microbiome for autism: From diagnosis to treatment